Cover Page

Course: WB 4342
CE Original Date: March 20, 2020
CE Expiration Date: March 20, 2022
Download Printer-Friendly version pdf icon[PDF – 859 KB]

Key Concepts
  • Ethylene glycol ingestion first affects the central nervous system (CNS). After a characteristic latent period, toxic metabolites might produce signs of inebriation followed by serious illness and even death.
  • No studies were located regarding a link between ethylene glycol exposure and cancer or reproductive or developmental hazards in humans.
  • Propylene glycol is much less toxic than ethylene glycol.
About This and Other Case Studies in Environmental Medicine

This educational case study is one in a series of self-instructional modules designed to increase the primary care provider’s knowledge of hazardous substances in the environment. The modules also promote adoption of medical practices that aid in the evaluation and care of potentially exposed patients. You can access the complete series of Case Studies in Environmental Medicine on the Agency for Toxic Substances and Disease Registry (ATSDR) website at URL: https://www.atsdr.cdc.gov/emes/health_professionals/index.html.

A downloadable PDF pdf icon[PDF – 841 KB] version of this educational series and other environmental medicine materials provides content in an electronic, printable format, especially for those who might lack adequate Internet service.

Acknowledgments

We gratefully acknowledge the work of the medical writers, editors, and reviewers in producing this educational resource. Listed below are the contributors to this version of the Case Study in Environmental Medicine.

Please Note: Each content expert for this case study has indicated that there is no conflict of interest to disclose that would bias the case study content.

ATSDR Authors: Dianyi Yu, MD

ATSDR Planners: Charlton Coles, PhD; Sharon L. Hall, PhD; Delene Roberts MSMHC; Julia Smith, MPH, CHES; Germania Pinheiro MD, MSc, PhD; Dianyi Yu, MD

Peer Reviewers: Obaid Faroon, DVM, PhD, and Ki Moon Bang, PhD, MPH

ATSDR Commenters: Alaina Steck, MD

How to Apply for and Receive CE Including the Assessment and Posttest

In order to receive CE for WB4342 – ATSDR CSEM: Ethylene Glycol/Propylene Glycol Toxicity please visit TCEO and follow these 9 Simple Steps before March 20, 2022

Complete the activity
Complete the Evaluation at  www.cdc.gov/GetCE
Pass the posttest at ___80___% at www.cdc.gov/GetCE

To receive free continuing education, please visit the CSEM Ethylene Glycol/Propylene Glycol Toxicity registration page

Continuing Education Information
Accrediting Organization CE Offered
ACCREDITATION STATEMENTS:

Accreditation Council for Continuing Medical Education (ACCME)

The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE The Centers for Disease Control and Prevention designates this activity for 1.6 nursing contact hours.
CEU The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU’s for this program.
CECH Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. Continuing Competency credits available are 1.5. CDC provider number 98614.
CPH The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
Disclaimer and Disclosure
Disclaimer

What we know about treating patients potentially exposed to hazardous substances in the environment is constantly evolving and is often uncertain. In developing its educational products, the Agency for Toxic Substances and Disease Registry (ATSDR) has worked hard to ensure the accuracy and the currency of the presented information. However, ATSDR makes no claim that the environmental medicine and health education resources discussed in these products comprehensively address all possible situations related to various substances. These products are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients potentially exposed to hazardous substances. The products are not a substitute for a healthcare provider’s professional judgment. Please interpret the environmental medicine and the health education resources in light of specific information regarding the patient and in conjunction with other medical authorities.

Use of trade names in ATSDR products is for identification purposes only and does not imply endorsement by the ATSDR or the U.S. Department of Health and Human Services.

Disclosure

In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

department of health and human services logo

U.S. Department of Health and Human Services
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Environmental Medicine
Environmental Medicine and Educational Services Branch

Page last reviewed: October 23, 2020